29/07/2013

Evaluation of a rapid and simple placental growth factor test in hypertensive disorders of pregnancy

jul 29th, 2013. En: Propuestas del editor.

Estudios importantes sobre hipertension arterial de Cuba y el mundo

Evaluation of a rapid and simple placental growth factor test in hypertensive disorders of pregnancy

Por: Nóra Gullai, Balázs Stenczer, Attila Molvarec, Gergely Fügedi, Zoltán Veresh, Bálint Nagy y János Rigó Jr. Hypertension Research (2013) 36, 457–462; doi.

The aim of this study was to investigate the diagnostic accuracy of the Triage placental growth factor (PlGF) assay, together with its prognostic efficiency in determining the need for preterm delivery in all forms of hypertensive disorders of pregnancy. A total of 130 pregnant women with a diagnosis of preeclampsia (PE: 23), HELLP syndrome (20), superimposed preeclampsia (SIPE: 17), chronic hypertension (CHT: 25), gestational hypertension (GHT: 18) and 27 normotensive pregnant controls were enrolled in this case-control study. A single blood sample was taken between 22 and 34 weeks of gestation, and the plasma was analyzed for PlGF using the Alere Triage PlGF assay. [Actualizado: 29 de julio 2013].